LOUISVILLE, Ky. / Jul 15, 2025 / Business Wire / Humana Inc. [NYSE: HUM] announced today its latest collaboration with healthcare software company Epic, becoming the first health insurer to integrate health plan information directly into the MyChart accounts patients may already use with their healthcare providers.
This enables Humana Medicare Advantage members to access their insurance details – such as vital coverage information, benefits, contacts and other resources – in the same place where they manage the rest of their care.
“We are dedicated to making our members’ healthcare experience as smooth and effortless as possible,” said George Renaudin, Humana’s President of Insurance. “This integration not only simplifies access to critical plan details but also empowers members to manage their health effectively.”
With over 3 million of Humana's members already using MyChart, this partnership with Epic marks a significant milestone in integrating care delivery with health plan information.
“Navigating healthcare can be complex, especially when information lives in different places,” said Alan Hutchison, Vice President at Epic. “This collaboration aims to make things simpler by bringing care and coverage together for patients.”
How Does It Work?
How Does It Help Patients?
This innovative feature enables members to conveniently access their health plan's information, increasing transparency and reducing the effort required to find critical details about their coverage and health plan resources.
About Humana:
Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we strive to make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.
Last Trade: | US$237.32 |
Daily Change: | 8.11 3.54 |
Daily Volume: | 890,139 |
Market Cap: | US$28.640B |
July 22, 2025 April 30, 2025 February 11, 2025 November 12, 2024 October 30, 2024 |
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREC4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MOREEnd of content
No more pages to load